CD4/CD8 double‐negative T‐cell lymphoma successfully treated with a combination of bexarotene and total skin electron beam therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD4/CD8 double‐negative T‐cell lymphoma successfully treated with a combination of bexarotene and total skin electron beam therapy

Published:2023-02-05 Issue:7 Volume:50 Page:
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:The Journal of Dermatology

Author:

Tanigawa Ayano¹,Fukumoto Takeshi¹^ORCID,Imamura Shinya¹^ORCID,Nakamura Korefumi¹,Tanaka Tomonori²,Itoh Tomoo²,Nakano Eiji¹^ORCID,Nishigori Chikako¹^ORCID,Kubo Akiharu¹

Affiliation:

1. Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine Kobe Japan

2. Division of Pathology, Department of Internal Related Kobe University Graduate School of Medicine Kobe Japan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.16739

Reference5 articles.

1. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: An immunohistochemical variant of mycosis fungoides

2. CD4/CD8 Double-negative T-cell Lymphoma: A Variant of Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma?

3. Bexarotene

4. Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results

5. Low‐dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T‐cell lymphoma;Elsayad K;J Dtsch Dermatol Ges,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP